Showing results (1901-1910 of 2,625) with videos related to

Sort By:
Pageof 263
Investigational New Drugs|September 1, 2021
A phase i study of ixazomib and erlotinib in patients with advanced solid tumorsShumei Kato, Jacob J Adashek, Vivek Subbiah, et al.
World Neurosurgery|October 4, 2020
Characteristics of Reported Industry Payments to Neurosurgeons: A 5-Year Open Payments Database StudyAladine A Elsamadicy, Isaac G Freedman, Andrew B Koo, et al.
The American Journal of Sports Medicine|February 9, 2022
Isolated Osteochondral Autograft Versus Allograft Transplantation for the Treatment of Symptomatic Cartilage Lesions of the Knee: A Systematic Review and Meta-analysisDavid P Trofa, Ian S Hong, Cesar D Lopez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseasesViktor Roschke, Svetlana Sosnovtseva, Christopher D Ward, et al.
JCI Insight|September 24, 2016
Analysis of cystic fibrosis-associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseasesCarleen M Sabusap, Wei Wang, Carmel M McNicholas, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|October 1, 2009
Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or olderR H Mak, H J Mamon, D P Ryan, et al.
Neurosurgery|October 15, 2011
Accelerator-based stereotactic radiosurgery for brainstem metastasesChun-Shu Lin, Michael T Selch, Steve P Lee, et al.
Brain Research|December 15, 1995
Glia-dependent neurotoxicity and neuroprotection in mesencephalic culturesD M Bronstein, I Perez-Otano, V Sun, et al.
Pancreas|November 16, 2016
Predictors of Early Mortality After Surgical Resection of Pancreatic Adenocarcinoma in the Era of Neoadjuvant TreatmentRyan D Nipp, Andrea Zanconato, Hui Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
A phase I clinical trial of darinaparsin in patients with refractory solid tumorsApostolia Maria Tsimberidou, Luis H Camacho, Srdan Verstovsek, et al.
Pageof 263